Xortx Therapeutics Inc. Stock
Price
Target price
€0.79
€0.79
2.600%
0.02
2.600%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Xortx Therapeutics Inc. Stock
Xortx Therapeutics Inc. gained 2.600% today.
Our community identified positive and negative aspects for Xortx Therapeutics Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Xortx Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Xortx Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
XORTX Announces USD $3 Million Offering
- Proceeds will be used to advance XORTX’s programs for gout -
CALGARY, AB – May 19, 2025 – XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt:
XORTX Provides Update on FDA Type B Meeting Request
XORTX will focus on key steps to advance a NDA filing for Gout indication
CALGARY, AB – April 30, 2025 – XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX |
XORTX Announces Grant of European Patent
- Patent Supporting Gout and Autosomal Dominant Polycystic Kidney Disease Programs -
CALGARY, AB – April 28, 2025 – XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX |